急诊ERCP在急性胆源性胰腺炎早期治疗中的应用  

Application of Emergency ERCP in the Early Treatment of Acute Biliary Pancreatitis

作　　者：王富华[1] 章杰[1] 朱建臣[1] 龙丹[1] 

机构地区：[1]龙岩市第二医院消化内科,福建龙岩36400

出　　处：《中外医疗》2017年第14期45-46,52,共3页China & Foreign Medical Treatment

基　　金：福建省引进重大研发机构资助项目(2014I2003)

摘　　要：目的探究急诊ERCP在急性胆源性胰腺炎(ABP)早期治疗中的应用效果。方法方便选取该院2014年1月—2016年6月接收90例急性胆源性胰腺炎患者作为研究对象,分为观察组与对照组,每组45例。分别给予急诊ERCP治疗(观察组)与常规保守治疗(对照组),比较两组患者预后指标变化及并发症发生率。结果观察组治疗后疼痛缓解时间(2.03±0.18)d及住院时间(10.33±2.05)d缩短,血淀粉酶(61.23±13.08)U/L、谷丙转氨酶(200.36±56.04)U/L及总胆红素(113.58±12.64)μmol/L均降低,效果优于对照组(P<0.05);两组患者在并发症发生率以及病死率差异无统计学意义(P>0.05)。结论急诊ERCP可显著提升患者预后,改善患者炎性症状,其应用治疗安全性高,值得临床推广。Objective To study the application effect of emergency ERCP in the early treatment of acute biliary pancreatitis.Methods 90 cases of patients with acute biliary pancreatitis admitted and treated in our hospital from January 2014 to June 2016 were conveniently selected and divided into two groups with 45 cases in each,and the observation group and the control group respectively adopted the ERCP treatment and routine conservative treatment,and the prognosis index changes and incidence rate of complications were compared between the two groups.Results After treatment,the pains relief time and length of stay in the observation group were shortened,which were respectively(2.03±0.18)d and(10.33±2.05)d,and the hemodlastase,glutamic-pyruvic transaminase and total bilirubin decreased and the effect was better than that in the control group[(61.23±13.08)U/L,(200.36 56.14)U/L,(113.58±12.64)μmol/L](P<0.05),and three were no obvious differences in the incidence rate of complications and morbidity between the two groups(P>0.05).Conclusion The emergency ERCP can obviously improve the prognosis of patients and improve the inflammatory symptoms with high treatment safety,which is worth clinical promotion.

关 键 词：急诊 ERCP 急性胆源性胰腺炎 

分 类 号：R5[医药卫生—内科学]